Qingdao Haier BiomedicalLtd Future Growth
Future criteria checks 5/6
Qingdao Haier BiomedicalLtd is forecast to grow earnings and revenue by 30.1% and 24% per annum respectively. EPS is expected to grow by 30.1% per annum. Return on equity is forecast to be 13.5% in 3 years.
Key information
30.1%
Earnings growth rate
30.1%
EPS growth rate
| Medical Equipment earnings growth | 26.5% |
| Revenue growth rate | 24.0% |
| Future return on equity | 13.5% |
| Analyst coverage | Low |
| Last updated | 10 Sep 2024 |
Recent future growth updates
Recent updates
Qingdao Haier BiomedicalLtd's (SHSE:688139) Weak Earnings May Only Reveal A Part Of The Whole Picture
Nov 06
Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Stock Rockets 38% But Many Are Still Ignoring The Company
Oct 03What Is Qingdao Haier Biomedical Co.,Ltd's (SHSE:688139) Share Price Doing?
Sep 23A Piece Of The Puzzle Missing From Qingdao Haier Biomedical Co.,Ltd's (SHSE:688139) Share Price
Aug 19Is Qingdao Haier BiomedicalLtd (SHSE:688139) A Risky Investment?
Jun 14Is Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Potentially Undervalued?
May 21Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce
Apr 26Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce
Apr 26Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4,027 | 813 | N/A | 906 | 3 |
| 12/31/2025 | 3,346 | 672 | N/A | 684 | 3 |
| 12/31/2024 | 2,747 | 542 | N/A | 664 | 3 |
| 9/30/2024 | 2,237 | 358 | 54 | 196 | N/A |
| 6/30/2024 | 2,234 | 362 | 35 | 195 | N/A |
| 3/31/2024 | 2,281 | 406 | 33 | 220 | N/A |
| 12/31/2023 | 2,281 | 406 | 72 | 249 | N/A |
| 9/30/2023 | 2,615 | 497 | 385 | 606 | N/A |
| 6/30/2023 | 2,867 | 579 | 294 | 562 | N/A |
| 3/31/2023 | 2,987 | 625 | 358 | 641 | N/A |
| 12/31/2022 | 2,864 | 601 | 338 | 632 | N/A |
| 9/30/2022 | 2,681 | 608 | 82 | 342 | N/A |
| 6/30/2022 | 2,466 | 573 | 315 | 559 | N/A |
| 3/31/2022 | 2,276 | 539 | 334 | 565 | N/A |
| 12/31/2021 | 2,126 | 845 | 387 | 592 | N/A |
| 9/30/2021 | 1,941 | 807 | 556 | 730 | N/A |
| 6/30/2021 | 1,735 | 799 | 566 | 681 | N/A |
| 3/31/2021 | 1,549 | 732 | 708 | 777 | N/A |
| 12/31/2020 | 1,402 | 381 | 608 | 697 | N/A |
| 9/30/2020 | 1,266 | 321 | 427 | 522 | N/A |
| 6/30/2020 | 1,166 | 254 | 277 | 409 | N/A |
| 3/31/2020 | 1,078 | 223 | 116 | 278 | N/A |
| 12/31/2019 | 1,013 | 182 | 112 | 280 | N/A |
| 9/30/2019 | 952 | 173 | 27 | 207 | N/A |
| 12/31/2018 | 842 | 114 | 80 | 149 | N/A |
| 12/31/2017 | 621 | 60 | N/A | 148 | N/A |
| 12/31/2016 | 482 | 123 | N/A | 221 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688139's forecast earnings growth (30.1% per year) is above the savings rate (2.8%).
Earnings vs Market: 688139's earnings (30.1% per year) are forecast to grow faster than the CN market (26.3% per year).
High Growth Earnings: 688139's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688139's revenue (24% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 688139's revenue (24% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688139's Return on Equity is forecast to be low in 3 years time (13.5%).